EP Global Communications, Inc . (EPGL), (the Company), (Pink Sheets: EPGL), ( www.eparent.com), the parent company of Exceptional Parent ( EP) magazine, has announced that its President and CEO, Joseph M. Valenzano Jr., participated in a videotaped question and answer session for the benefit of investors. “This will be an important video interview with significant information directly from the CEO himself on our recent activities,” explained EPGL Chief Financial Officer, James McGinnis. “We encourage all investors to watch as the interview should be valuable and informative as we move closer to November's WCD conference in Dallas, Texas, November 18-19, 2010. Mr. Valenzano looks forward to elaborating on how recent developments are very significant to our family of investors, caregivers, readers, and clients.” The video Q&A can be accessed at www.eparent.com and on Investment Nation, http://investmentnation.com. Additionally, it will be distributed on YouTube other popular video sharing websites. About EP Global Communications, Inc. EP Global Communications, Inc., parent company of Exceptional Parent ( EP) magazine, is a 40-year-old, award-winning, multi-media publishing and communications company, providing timely and indispensable resources and information to families and professionals caring for the needs of children and adults with disabilities and special health care needs, including families in the U.S. Military. Safe Harbor StatementCertain matters discussed in this press release are "forward-looking statements" intended to qualify for the safe harbors from liability established by the Private Securities Litigation Reform Act of 1995. In particular, the Company's statements regarding trends in the marketplace and potential future results are examples of such forward-looking statements. The forward-looking statements include risks and uncertainties, including, but not limited to, the timing of projects due to the variability in size, scope and duration of projects, estimates made by management with respect to the Company's critical accounting policies, regulatory delays, clinical study results which lead to reductions or cancellations of projects, and other factors, including general economic conditions and regulatory developments, not within the Company's control. The forward-looking statements are made only as of the date of this press release and the Company undertakes no obligation to publicly update such forward-looking statements to reflect subsequent events or circumstances.